Dirk Beher, CEO, will present on “O-GlcNAcase inhibitors for tauopathies – translation of a research finding to a clinical candidate molecule” (Time TBC).
The 1st EuroTauMeeting will be held at the School of Medicine (Faculté de Médecine) in Lille, France, on April 27-28, 2017, with the support of DN2M (Federation in Neurosciences at the Univ. Lille) and LiCEND (Lille Centre of Excellence in Neurodegenerative Disorders).
With the objective to build a European consortium on Tau proteins and Tauopathies, European scientists involved in Tau research will gather during two days to exchange new ideas and hypotheses on physiological and pathological roles of tau proteins.
Further information: http://lucbuee.fr/crbst_10.html